vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Utz Brands, Inc. (UTZ). Click either name above to swap in a different company.
Utz Brands, Inc. is the larger business by last-quarter revenue ($341.0M vs $284.0M, roughly 1.2× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 0.7%, a 95.7% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -3.1%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -1.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Utz Brands, Inc., more commonly known as Utz, is an American snack food company based in Hanover, Pennsylvania. The company produces a variety of potato chips, pretzels, and other snacks, with most products sold under their family of brands. Utz is also a snack supplier to warehouse clubs and merchandisers.
ACAD vs UTZ — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $341.0M |
| Net Profit | $273.6M | $2.3M |
| Gross Margin | 90.8% | 25.5% |
| Operating Margin | 6.1% | 2.1% |
| Net Margin | 96.3% | 0.7% |
| Revenue YoY | 9.4% | -3.1% |
| Net Profit YoY | 90.3% | 108.3% |
| EPS (diluted) | $1.61 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | — | ||
| Q2 25 | $264.6M | — | ||
| Q1 25 | $244.3M | — | ||
| Q4 24 | $259.6M | $341.0M | ||
| Q3 24 | $250.4M | $365.5M | ||
| Q2 24 | $242.0M | $356.2M | ||
| Q1 24 | $205.8M | $346.5M |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | — | ||
| Q2 25 | $26.7M | — | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $143.7M | $2.3M | ||
| Q3 24 | $32.8M | $-2.2M | ||
| Q2 24 | $33.4M | $19.8M | ||
| Q1 24 | $16.6M | $-4.0M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | 25.5% | ||
| Q3 24 | 92.5% | 26.9% | ||
| Q2 24 | 92.5% | 26.7% | ||
| Q1 24 | 88.8% | 25.5% |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | — | ||
| Q2 25 | 12.2% | — | ||
| Q1 25 | 7.9% | — | ||
| Q4 24 | 59.1% | 2.1% | ||
| Q3 24 | 12.6% | 5.3% | ||
| Q2 24 | 12.6% | 6.3% | ||
| Q1 24 | 7.4% | 2.8% |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | — | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | 55.4% | 0.7% | ||
| Q3 24 | 13.1% | -0.6% | ||
| Q2 24 | 13.8% | 5.6% | ||
| Q1 24 | 8.0% | -1.2% |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.86 | $0.04 | ||
| Q3 24 | $0.20 | $-0.03 | ||
| Q2 24 | $0.20 | $0.23 | ||
| Q1 24 | $0.10 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $56.1M |
| Total DebtLower is stronger | — | $768.6M |
| Stockholders' EquityBook value | $1.2B | $696.9M |
| Total Assets | $1.6B | $2.7B |
| Debt / EquityLower = less leverage | — | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | $56.1M | ||
| Q3 24 | $155.1M | $64.9M | ||
| Q2 24 | $177.1M | $66.6M | ||
| Q1 24 | $204.7M | $47.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $768.6M | ||
| Q3 24 | — | $780.8M | ||
| Q2 24 | — | $797.6M | ||
| Q1 24 | — | $756.9M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | — | ||
| Q2 25 | $822.4M | — | ||
| Q1 25 | $765.2M | — | ||
| Q4 24 | $732.8M | $696.9M | ||
| Q3 24 | $577.2M | $685.7M | ||
| Q2 24 | $516.7M | $686.0M | ||
| Q1 24 | $464.0M | $671.1M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.2B | $2.7B | ||
| Q3 24 | $976.9M | $2.6B | ||
| Q2 24 | $914.1M | $2.7B | ||
| Q1 24 | $855.1M | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.10× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 1.13× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $54.2M |
| Free Cash FlowOCF − Capex | — | $16.5M |
| FCF MarginFCF / Revenue | — | 4.8% |
| Capex IntensityCapex / Revenue | — | 11.1% |
| Cash ConversionOCF / Net Profit | -0.18× | 23.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | — | ||
| Q2 25 | $64.0M | — | ||
| Q1 25 | $20.3M | — | ||
| Q4 24 | $40.4M | $54.2M | ||
| Q3 24 | $63.2M | $52.2M | ||
| Q2 24 | $25.0M | $8.9M | ||
| Q1 24 | $29.1M | $-9.1M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $16.5M | ||
| Q3 24 | $63.2M | $29.1M | ||
| Q2 24 | — | $-15.3M | ||
| Q1 24 | — | $-22.7M |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | 25.2% | 8.0% | ||
| Q2 24 | — | -4.3% | ||
| Q1 24 | — | -6.5% |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 11.1% | ||
| Q3 24 | 0.0% | 6.3% | ||
| Q2 24 | — | 6.8% | ||
| Q1 24 | — | 3.9% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | 23.67× | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | 0.45× | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
UTZ
Segment breakdown not available.
